메뉴 건너뛰기




Volumn 4, Issue 1, 2010, Pages 82-94

Bioavailability of oral drugs and the methods for its improvement

Author keywords

Drug bioavailability; Drug formulations; Enterocytes; Intestinal absorption; Lymphatic transport; Paracellular absorption; Phospholipid nanoparticles

Indexed keywords

ALPHA TOCOPHEROL; CAPRATE; CARRIER PROTEIN; CELL ENZYME; CHITOSAN; DOXORUBICIN; DRUG CARRIER; GLYCYRRHIZIC ACID; HALOFANTRINE; INDINAVIR; INDOMETACIN; MACROGOL; NANOPARTICLE; POVIDONE; PREDNISOLONE; RIBOFLAVIN; SALAZOSULFAPYRIDINE; UNCLASSIFIED DRUG;

EID: 77950246612     PISSN: 19907508     EISSN: 19907516     Source Type: Journal    
DOI: 10.1134/S1990750810010117     Document Type: Review
Times cited : (17)

References (74)
  • 1
    • 0036000312 scopus 로고    scopus 로고
    • A mechanistic approach to understanding the factors affecting drug absorption: A review of fundamentals
    • DOI 10.1177/00970002042006005
    • M.N. Martinez G.L. Amidon 2002 J. Clin. Pharmacol. 42 620 643 10.1177/00970002042006005 1:CAS:528:DC%2BD38Xks1OgsLc%3D (Pubitemid 34547446)
    • (2002) Journal of Clinical Pharmacology , vol.42 , Issue.6 , pp. 620-643
    • Martinez, M.N.1    Amidon, G.L.2
  • 6
    • 17844406157 scopus 로고    scopus 로고
    • Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: A target for drug delivery
    • DOI 10.2174/1567201052772834
    • M.J. Cano-Cebrián T. Zornoza L. Granero A. Polache 2005 Curr. Drug Deliv. 2 9 22 10.2174/1567201052772834 (Pubitemid 40590917)
    • (2005) Current Drug Delivery , vol.2 , Issue.1 , pp. 9-22
    • Cano-Cebrian, M.J.1    Zornoza, T.2    Granero, L.3    Polache, A.4
  • 8
    • 28444484982 scopus 로고    scopus 로고
    • Expression and function of efflux drug transporters in the intestine
    • DOI 10.1016/j.pharmthera.2005.06.005, PII S0163725805001373
    • M. Takano R. Yumoto T. Murakami 2006 Pharmacol. Ther. 109 137 161 10.1016/j.pharmthera.2005.06.005 1:CAS:528:DC%2BD2MXht12ktbbP (Pubitemid 41740818)
    • (2006) Pharmacology and Therapeutics , vol.109 , Issue.1-2 , pp. 137-161
    • Takano, M.1    Yumoto, R.2    Murakami, T.3
  • 10
    • 43749104916 scopus 로고    scopus 로고
    • 10.2133/dmpk.23.87 1:CAS:528:DC%2BD1cXotVynurk%3D
    • M. Kato 2008 Drug Metab. Pharmacokinet. 23 87 94 10.2133/dmpk.23.87 1:CAS:528:DC%2BD1cXotVynurk%3D
    • (2008) Drug Metab. Pharmacokinet. , vol.23 , pp. 87-94
    • Kato, M.1
  • 12
    • 0035940068 scopus 로고    scopus 로고
    • Transport and absorption of drugs via the lymphatic system
    • DOI 10.1016/S0169-409X(01)00146-6, PII S0169409X01001466
    • C.J. Porter W.N. Charman 2001 Adv. Drug Deliv. Rev. 50 1 2 10.1016/S0169-409X(01)00146-6 1:CAS:528:DC%2BD3MXlsF2js7w%3D (Pubitemid 32727273)
    • (2001) Advanced Drug Delivery Reviews , vol.50 , Issue.1-2 , pp. 1-2
    • Porter, C.J.H.1    Charman, W.N.2
  • 16
    • 0037404360 scopus 로고    scopus 로고
    • Effect of N-acetylcysteine on microcirculation of mucosa in rat ileum in a model of intestinal inflammation
    • DOI 10.1023/A:1023087226504
    • J. Ruh E. Schmidt F. Vogel 2003 Dig. Dis. Sci. 48 882 889 10.1023/A:1023087226504 1:CAS:528:DC%2BD3sXis1Cjsrs%3D (Pubitemid 36470206)
    • (2003) Digestive Diseases and Sciences , vol.48 , Issue.5 , pp. 882-889
    • Ruh, J.1    Schmidt, E.2    Vogel, F.3
  • 18
  • 22
    • 33847394968 scopus 로고    scopus 로고
    • Lipids and lipid-based formulations: Optimizing the oral delivery of lipophilic drugs
    • DOI 10.1038/nrd2197, PII NRD2197
    • C.J. Porter N.L. Trevaskis W.N. Charman 2007 Nat. Rev. Drug Discov. 6 231 248 10.1038/nrd2197 1:CAS:528:DC%2BD2sXit12rsbY%3D (Pubitemid 46344627)
    • (2007) Nature Reviews Drug Discovery , vol.6 , Issue.3 , pp. 231-248
    • Porter, C.J.H.1    Trevaskis, N.L.2    Charman, W.N.3
  • 23
    • 51649104303 scopus 로고    scopus 로고
    • 10.2165/00003088-200847100-00003 1:CAS:528:DC%2BD1cXhtlaitrvI
    • J.B. Dressman K. Thelen E. Jantratid 2008 Clin. Pharmacokinet. 47 655 667 10.2165/00003088-200847100-00003 1:CAS:528:DC%2BD1cXhtlaitrvI
    • (2008) Clin. Pharmacokinet. , vol.47 , pp. 655-667
    • Dressman, J.B.1    Thelen, K.2    Jantratid, E.3
  • 25
    • 39149115065 scopus 로고    scopus 로고
    • 10.1016/j.addr.2007.08.043 1:CAS:528:DC%2BD1cXitVOmsr0%3D
    • J.M. Custodio C.-Y. Wu L.Z. Benet 2008 Adv. Drug Deliv. Rev. 60 717 733 10.1016/j.addr.2007.08.043 1:CAS:528:DC%2BD1cXitVOmsr0%3D
    • (2008) Adv. Drug Deliv. Rev. , vol.60 , pp. 717-733
    • Custodio, J.M.1    Wu, C.-Y.2    Benet, L.Z.3
  • 26
    • 0345275778 scopus 로고    scopus 로고
    • Modeling of intestinal drug absorption: Roles of transporters and metabolic enzymes (for the gillette review series)
    • DOI 10.1124/dmd.31.12.1507
    • K.S. Pang 2003 Drug Metab. Dispos. 31 1507 1519 10.1124/dmd.31.12.1507 1:CAS:528:DC%2BD3sXpt1KgsLo%3D (Pubitemid 37466919)
    • (2003) Drug Metabolism and Disposition , vol.31 , Issue.12 , pp. 1507-1519
    • Pang, K.S.1
  • 32
    • 33746905966 scopus 로고    scopus 로고
    • An acute and coincident increase in FABP expression and lymphatic lipid and drug transport occurs during intestinal infusion of lipid-based drug formulations to rats
    • DOI 10.1007/s11095-006-9021-6
    • N.L. Trevaskis C.M. Lo L.Y. Ma P. Tso H.R. Irving C.J. Porter W.N. Charman 2006 Pharm. Res. 23 1786 1796 10.1007/s11095-006-9021-6 1:CAS:528:DC%2BD28XnvVymtrw%3D (Pubitemid 44200542)
    • (2006) Pharmaceutical Research , vol.23 , Issue.8 , pp. 1786-1796
    • Trevaskis, N.L.1    Lo, C.M.2    Ma, L.Y.3    Tso, P.4    Irving, H.R.5    Porter, C.J.H.6    Charman, W.N.7
  • 33
    • 35648987134 scopus 로고    scopus 로고
    • Cytoplasmic fatty acid binding protein sensing fatty acids for peroxisome proliferator activated receptor activation
    • DOI 10.1007/s00018-007-7279-4
    • C. Wolfrum 2007 Cell Mol. Life Sci. 64 2465 2476 10.1007/s00018-007-7279- 4 1:CAS:528:DC%2BD2sXhtlSitbvM (Pubitemid 350035620)
    • (2007) Cellular and Molecular Life Sciences , vol.64 , Issue.19-20 , pp. 2465-2476
    • Wolfrum, C.1
  • 34
    • 1442357806 scopus 로고    scopus 로고
    • Enterocyte fatty acid uptake and intestinal fatty acid-binding protein
    • DOI 10.1042/BST0320075
    • P. Tso A. Nauli C.M. Lo 2004 Biochem. Soc. Trans. 32 75 78 10.1042/BST0320075 1:CAS:528:DC%2BD2cXisVGrt7w%3D (Pubitemid 38283017)
    • (2004) Biochemical Society Transactions , vol.32 , Issue.1 , pp. 75-78
    • Tso, P.1    Nauli, A.2    Lo, C.-M.3
  • 35
    • 33644684769 scopus 로고    scopus 로고
    • Transporters and drug discovery: Why, when, and how
    • DOI 10.1021/mp050084o
    • R.B. Kim 2006 Molecular Pharmaceutics 3 26 32 10.1021/mp050084o 1:CAS:528:DC%2BD28XlvV2r (Pubitemid 43331748)
    • (2006) Molecular Pharmaceutics , vol.3 , Issue.1 , pp. 26-32
    • Kim, R.B.1
  • 36
    • 34247232179 scopus 로고    scopus 로고
    • Examination of the Role of Intestinal Fatty Acid-Binding Protein in Drug Absorption Using a Parallel Artificial Membrane Permeability Assay
    • DOI 10.1016/j.chembiol.2007.03.009, PII S1074552107001068
    • T. Velkov J. Horne A. Laguerre E. Jones M.J. Scanlon C.J. Porter 2007 Chem. Biol. 14 453 465 10.1016/j.chembiol.2007.03.009 1:CAS:528: DC%2BD2sXkslaiur8%3D (Pubitemid 46617321)
    • (2007) Chemistry and Biology , vol.14 , Issue.4 , pp. 453-465
    • Velkov, T.1    Horne, J.2    Laguerre, A.3    Jones, E.4    Scanlon, M.J.5    Porter, C.J.H.6
  • 37
    • 0141569628 scopus 로고    scopus 로고
    • Expression profiles of drug-metabolizing enzyme CYP3A and drug efflux transporter multidrug resistance 1 subfamily mRNAs in rat small intestine
    • DOI 10.1124/dmd.31.10.1235
    • K. Takara N. Ohnishi S. Horibe T. Yokoyama 2003 Drug Metab. Dispos. 31 1235 1239 10.1124/dmd.31.10.1235 1:CAS:528:DC%2BD3sXnslKitr0%3D (Pubitemid 37152974)
    • (2003) Drug Metabolism and Disposition , vol.31 , Issue.10 , pp. 1235-1239
    • Takara, K.1    Ohnishi, N.2    Horibe, S.3    Yokoyama, T.4
  • 38
    • 29944442940 scopus 로고    scopus 로고
    • Determination of the enzyme(s) involved in the metabolism of amiodarone in liver and intestine of rat: The contribution of cytochrome P450 3A isoforms
    • DOI 10.1124/dmd.105.006742
    • A. Shayeganpour A.O. El-Kadi D.R. Brocks 2006 Drug Metab. Dispos. 34 43 50 10.1124/dmd.105.006742 1:CAS:528:DC%2BD28Xhslyjsg%3D%3D (Pubitemid 43042645)
    • (2006) Drug Metabolism and Disposition , vol.34 , Issue.1 , pp. 43-50
    • Shayeganpour, A.1    El-Kadi, A.O.S.2    Brocks, D.R.3
  • 41
    • 0033010386 scopus 로고    scopus 로고
    • Differences in the lipoprotein distribution of halofantrine are regulated by lipoprotein apolar lipid and protein concentration and lipid transfer protein I activity: In vitro studies in normolipidemic and dyslipidemic human plasmas
    • DOI 10.1021/js980353k
    • K.M. Wasan M. Ramaswamy M.P. McIntosh C.J. Porter W.N. Charman 1999 J. Pharm. Sci. 88 185 190 10.1021/js980353k 1:CAS:528:DyaK1MXos1yh (Pubitemid 29084729)
    • (1999) Journal of Pharmaceutical Sciences , vol.88 , Issue.2 , pp. 185-190
    • Wasan, K.M.1    Ramaswamy, M.2    McIntosh, M.P.3    Porter, C.J.H.4    Charman, W.N.5
  • 43
    • 0030993565 scopus 로고    scopus 로고
    • The oral absorption of micro- and nanoparticulates: Neither exceptional nor unusual
    • DOI 10.1023/A:1012029517394
    • A.T. Florence 1997 Pharm. Res. 14 259 266 10.1023/A:1012029517394 1:CAS:528:DyaK2sXisVGlsro%3D (Pubitemid 27160935)
    • (1997) Pharmaceutical Research , vol.14 , Issue.3 , pp. 259-266
    • Florence, A.T.1
  • 47
    • 35449006733 scopus 로고    scopus 로고
    • Tight junction modulators: Promising candidates for drug delivery
    • DOI 10.2174/092986707782023640
    • M. Kondoh K. Yagi 2007 Curr. Med. Chem. 14 2482 2488 10.2174/ 092986707782023640 1:CAS:528:DC%2BD2sXhtVKqtrnF (Pubitemid 47618036)
    • (2007) Current Medicinal Chemistry , vol.14 , Issue.23 , pp. 2482-2488
    • Kondoh, M.1    Yagi, K.2
  • 48
    • 34249951078 scopus 로고    scopus 로고
    • 10.2133/dmpk.22.67 1:CAS:528:DC%2BD2sXms1Omtb4%3D
    • M. Hayashi M. Tomita 2007 Drug Metab. Pharmacokinet. 22 67 77 10.2133/dmpk.22.67 1:CAS:528:DC%2BD2sXms1Omtb4%3D
    • (2007) Drug Metab. Pharmacokinet. , vol.22 , pp. 67-77
    • Hayashi, M.1    Tomita, M.2
  • 49
    • 0035940059 scopus 로고    scopus 로고
    • Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics
    • DOI 10.1016/S0169-409X(01)00152-1, PII S0169409X01001521
    • N. Hussain V. Jaitley A.T. Florence 2001 Adv. Drug Deliv. Rev. 50 107 142 10.1016/S0169-409X(01)00152-1 1:CAS:528:DC%2BD3MXlsF2js7Y%3D (Pubitemid 32727279)
    • (2001) Advanced Drug Delivery Reviews , vol.50 , Issue.1-2 , pp. 107-142
    • Hussain, N.1    Jaitley, V.2    Florence, A.T.3
  • 50
    • 0035478442 scopus 로고    scopus 로고
    • Transcytosis of nanoparticle and dendrimer delivery systems: Evolving vistas
    • DOI 10.1016/S0169-409X(01)00184-3, PII S0169409X01001843
    • A.T. Florence N. Hussain 2001 Adv. Drug Deliv. Rev 50 S69 S89 10.1016/S0169-409X(01)00184-3 1:CAS:528:DC%2BD3MXntVWku78%3D (Pubitemid 32905356)
    • (2001) Advanced Drug Delivery Reviews , vol.50 , Issue.SUPPL. 1
    • Florence, A.T.1    Hussain, N.2
  • 52
    • 2942702257 scopus 로고    scopus 로고
    • Issues in oral nanoparticle drug carrier uptake and targeting
    • DOI 10.1080/10611860410001693706, Cellular Aspects of Targeting in the Gastrointestinal Tract
    • A.T. Florence 2004 J. Drug Target 12 65 70 10.1080/10611860410001693706 1:CAS:528:DC%2BD2cXktVCqtbo%3D (Pubitemid 38786914)
    • (2004) Journal of Drug Targeting , vol.12 , Issue.2 , pp. 65-70
    • Florence, A.T.1
  • 58
    • 0025804183 scopus 로고
    • 10.1016/0006-291X(91)91647-U 1:CAS:528:DyaK3MXhslOrt7c%3D
    • P. Artursson J. Karlsson 1991 Biochem. Biophys. Res. Commun. 175 880 885 10.1016/0006-291X(91)91647-U 1:CAS:528:DyaK3MXhslOrt7c%3D
    • (1991) Biochem. Biophys. Res. Commun. , vol.175 , pp. 880-885
    • Artursson, P.1    Karlsson, J.2
  • 59
    • 0033963413 scopus 로고    scopus 로고
    • Effects of sodium deoxycholate and sodium caprate on the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats
    • DOI 10.1016/S0006-2952(99)00377-9, PII S0006295299003779
    • Y.L. Lo J.D. Huang 2000 Biochem. Pharmacol. 59 665 672 10.1016/S0006-2952(99)00377-9 1:CAS:528:DC%2BD3cXhtFaltLg%3D (Pubitemid 30085448)
    • (2000) Biochemical Pharmacology , vol.59 , Issue.6 , pp. 665-672
    • Lo, Y.-L.1    Huang, J.-D.2
  • 61
    • 35248822616 scopus 로고    scopus 로고
    • The utility of cyclodextrins for enhancing oral bioavailability
    • DOI 10.1016/j.jconrel.2007.07.018, PII S0168365907004129
    • R.L. Carrier L.A. Miller I. Ahmed 2007 J. Control Release 123 78 99 10.1016/j.jconrel.2007.07.018 1:CAS:528:DC%2BD2sXhtFyku7fI (Pubitemid 47566400)
    • (2007) Journal of Controlled Release , vol.123 , Issue.2 , pp. 78-99
    • Carrier, R.L.1    Miller, L.A.2    Ahmed, I.3
  • 62
    • 33751512735 scopus 로고    scopus 로고
    • 10.2174/138161206779026245 1:CAS:528:DC%2BD2sXmsFCnsw%3D%3D
    • S.R. Croy G.S. Kwon 2006 Curr. Pharm. Des. 12 4669 4684 10.2174/138161206779026245 1:CAS:528:DC%2BD2sXmsFCnsw%3D%3D
    • (2006) Curr. Pharm. Des. , vol.12 , pp. 4669-4684
    • Croy, S.R.1    Kwon, G.S.2
  • 63
    • 4344578729 scopus 로고    scopus 로고
    • Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation
    • DOI 10.1023/B:PHAM.0000036914.22132.cc
    • C.J. Porter A.M. Kaukonen B.J. Boyd G.A. Edwards W.N. Charman 2004 Pharm. Res. 21 1405 1412 10.1023/B:PHAM.0000036914.22132.cc 1:CAS:528: DC%2BD2cXmtlGnurY%3D (Pubitemid 39149655)
    • (2004) Pharmaceutical Research , vol.21 , Issue.8 , pp. 1405-1412
    • Porter, C.J.H.1    Kaukonen, A.M.2    Boyd, B.J.3    Edwards, G.A.4    Charman, W.N.5
  • 65
    • 2342608569 scopus 로고    scopus 로고
    • Remote controlled capsules in human drug absorption (HDA) studies
    • DOI 10.1615/CritRevTherDrugCarrierSyst.v20.i6.10
    • I.R. Wikling D.V. Prior 2003 Crit. Rev. Ther. Drug Carrier Syst. 20 405 431 10.1615/CritRevTherDrugCarrierSyst.v20.i6.10 (Pubitemid 41646574)
    • (2003) Critical Reviews in Therapeutic Drug Carrier Systems , vol.20 , Issue.6 , pp. 405-431
    • Wilding, I.R.1    Prior, D.V.2
  • 66
    • 4544275025 scopus 로고    scopus 로고
    • Challenges and solutions for the delivery of biotech drugs - A review of drug nanocrystal technology and lipid nanoparticles
    • DOI 10.1016/j.jbiotec.2004.06.007, PII S0168165604003128
    • R.H. Muller C.M. Keck 2004 J. Biotechnol. 113 151 170 10.1016/j.jbiotec.2004.06.007 1:CAS:528:DC%2BD2cXnslOhtL4%3D (Pubitemid 39237077)
    • (2004) Journal of Biotechnology , vol.113 , Issue.1-3 , pp. 151-170
    • Muller, R.H.1    Keck, C.M.2
  • 67
    • 34250332586 scopus 로고    scopus 로고
    • Implication of nanoparticles/microparticles in mucosal vaccine delivery
    • DOI 10.1586/14760584.6.3.401
    • S.P. Vyas P.N. Gupta 2007 Expert Rev. Vaccines 6 401 418 10.1586/14760584.6.3.401 1:CAS:528:DC%2BD2sXmtVGit7g%3D (Pubitemid 46911603)
    • (2007) Expert Review of Vaccines , vol.6 , Issue.3 , pp. 401-418
    • Vyas, S.P.1    Gupta, P.N.2
  • 68
    • 34548049221 scopus 로고    scopus 로고
    • Oral lipid-based formulations
    • DOI 10.1016/j.addr.2007.05.006, PII S0169409X07000853
    • D.J. Hauss 2007 Adv. Drug Deliv. Rev. 59 667 676 10.1016/j.addr.2007.05. 006 1:CAS:528:DC%2BD2sXpsFGks7c%3D (Pubitemid 47285409)
    • (2007) Advanced Drug Delivery Reviews , vol.59 , Issue.7 , pp. 667-676
    • Hauss, D.J.1
  • 69
    • 39149113817 scopus 로고    scopus 로고
    • 10.1016/j.addr.2007.10.010 1:CAS:528:DC%2BD1cXitVOnu7s%3D
    • C.W. Pouton C.J. Porter 2008 Adv. Drug Deliv. Rev. 60 625 637 10.1016/j.addr.2007.10.010 1:CAS:528:DC%2BD1cXitVOnu7s%3D
    • (2008) Adv. Drug Deliv. Rev. , vol.60 , pp. 625-637
    • Pouton, C.W.1    Porter, C.J.2
  • 70
    • 0033805858 scopus 로고    scopus 로고
    • 10.1016/S0928-0987(00)00167-6
    • C.W. Pouton 2000 Eur. J. Pharm. Sci. 11Suppl2 S93 S98 10.1016/S0928-0987(00)00167-6
    • (2000) Eur. J. Pharm. Sci. , vol.112
    • Pouton, C.W.1
  • 71
    • 1842684453 scopus 로고    scopus 로고
    • Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs
    • DOI 10.1016/j.biopha.2004.02.001, PII S0753332204000319
    • R.N. Gursoy S. Benita 2004 Biomed. Pharmacother. 58 173 182 10.1016/j.biopha.2004.02.001 (Pubitemid 38479922)
    • (2004) Biomedicine and Pharmacotherapy , vol.58 , Issue.3 , pp. 173-182
    • Gursoy, R.N.1    Benita, S.2
  • 73
    • 0029926358 scopus 로고    scopus 로고
    • Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: Effect of lipid vehicle dispersion
    • DOI 10.1021/js950221g
    • C.J. Porter S.A. Charman W.N. Charman 1996 J. Pharm. Sci. 85 351 356 10.1021/js950221g 1:CAS:528:DyaK28XhsFShsL0%3D (Pubitemid 26105699)
    • (1996) Journal of Pharmaceutical Sciences , vol.85 , Issue.4 , pp. 351-356
    • Porter, C.J.H.1    Charman, S.A.2    Charman, W.N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.